Company intelligence / Profile preview

DYNEX Technologies

Chantilly, Virginia, United Statesdynextechnologies.com ↗
Ownership
Private
Employees
~115
Development stage
Commercial
01

Overview

DYNEX Technologies is a global leader in the design and manufacture of fully automated ELISA and chemiluminescence microplate instruments, supporting laboratories with over 8,500 installations worldwide. Their systems are ISO certified and FDA/IVDR/CE compliant, serving clinical diagnostics across more than 120 countries.

Modalities
Device (automated ELISA and chemiluminescence microplate instruments)
Industry
Protein Biomarker Diagnostics
02

Partnerships

Select global distributors (for service and support)

Beyond the preview

Go deeper on DYNEX Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DYNEX Technologies.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call